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Abstract The purpose is to analyse differences in mor-
tality among patients with major depressive disorders
(MDD), bipolar-II (BP-II), bipolar-I (BP-I) disorders and
mania with or without minor depressive disorders and to
identify risk factors of mortality. The sample represents all
admissions for depression or mania over 5 years
(1959–1963) to the Psychiatric Hospital of Zurich Uni-
versity, serving a large area. 403 patients were included
and followed up every 5 years until 1985; thereafter,
mortality data were collected repeatedly until 2009 when
352 (87 %) patients had died. Standardised mortality ratios
(SMRs) were computed and survival analyses applied.
With the exception of BP-II disorder, the three other
diagnostic groups showed elevated SMRs. The group with
mania had the highest SMR for cardiovascular deaths and
the group with MDD the highest for deaths by suicide.
Mortality was also high among patients with late-onset
MDD. Across the diagnostic spectrum, we found differ-
ences in risk factors for mortality, such as a family history
of suicides and personality type: more anxious patients
with MDD lived longer, and among patients with BP dis-
orders, more tense (aggressive) types had shorter lives.
Long-term medication had a protective effect against
mortality in patients with MDD during years 1–9 and in
patients with BP disorders during years 1–19 after
admission. We found marked differences in causes of death
and risk factors between subgroups of mood disorders. For
the purpose of further research, it would be recommendable
to distinguish pure mania from bipolar disorders.
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Introduction
Mood disorders are the most common psychiatric disor-
ders, with lifetime prevalence rates between 20 and 30 %
or higher in the general population. The WHO ranks the
burden of depression second among all medical disorders,
after cardiovascular diseases [1, 2].
Elevated mortality is an important aspect of the Global
Burden of Disease. It is generally assumed that depressed
patients have a shorter life expectancy, although a review
of the literature by Cole [3] raised some doubts in this
regard. Nonetheless, a number of the studies covered by the
review provide evidence that mortality is higher among
depressed patients even after adjustment for demographic
and medical risk factors [4] or disability [5]. In addition,
several sound prospective studies have demonstrated
increased mortality among elderly depressed patients
[5–12]. This was especially so for deaths by suicide within
the first 12 months of contact with the public mental health
service of England and Wales from 1996 to 2000
(N = 4,859); risk factors were living alone, recent
bereavement and physical illness [13].
The largest representative studies of the mortality of
patients admitted to psychiatric hospitals are those based
on population registers in Sweden and Denmark. In
Sweden, the standardised mortality ratios (SMRs) for death
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by suicide for 15,386 patients admitted to hospital for
bipolar disorder (BP) and 39,182 admitted for unipolar
disorders (UP) between 1973 and 1995 were 15.0 for men
with BP and 22.4 for women with BP, and 20.9 for men
with UP and 27.0 for women with UP [14]. Natural deaths
accounted for about half of the total mortality; the SMR
decreased with age. A Danish study confirmed a very high
risk of death by suicide among 54,103 patients with
affective disorders during the first 12 months following
their first admission compared to later years [15]. The
largest such study, by Munk Laursen et al. [16] in
Denmark, compared 105,841 of 261,886 patients admitted
to a psychiatric hospital who had died with the population
of 1,480,608 persons without psychiatric hospitalisation
who had died (years 1973–2001). Patients with unipolar
depressive disorder, bipolar disorder and schizoaffective
disorder had similar patterns of excess mortality. Among
patients hospitalised for mood disorders, mortality rate
ratios for suicide were much higher for women (UP 37.2
and BP 43.2) than for men (UP 25.9 and BP 24.0). Deaths
by homicide were also higher among women but deaths by
accident were higher among men with UP and BP. The
most recent studies suggest that the mortality rate among
patients with bipolar disorder is strongly elevated [17, 18]
and is higher among patients with bipolar-I (BP-I) disorder
than among those with bipolar-II (BP-II) disorder [16].
Prospective cohort studies of hospitalised patients con-
ducted over decades are both very rare and small in their
sample sizes but they can add to our understanding of fur-
ther correlates of mortality and the differences between
diagnostic subgroups of mood disorders. To our knowledge,
there are no studies on mortality lasting more than 40 years.
The present update can contribute to filling that gap.
The initial purpose of our 50-year-long prospective
cohort study was to describe the course and outcome of
mood disorders [19, 20]; subsequently, it aimed at deter-
mining (1) the mortality risk of subjects with severe
affective disorders, considering subgroups across the mood
spectrum from depression via bipolar subgroups to mania,
and comparing it to the mortality risk of the general pop-
ulation and (2) to identify the factors which were associ-
ated with mortality. In 2002, we presented the results of a
follow-up period of 34–38 years [21]; a second report
focussed especially on 45 suicides up to 2003 [22]. This
third paper covers a further 6 years up to 2009.
Methods
Patient sample
The sample of the present study consists of 406 patients,
representing all admissions to the Psychiatric Hospital of
Zurich University for major mood disorders between 1959
and 1963. Originally, that is, until 1985, the purpose of the
clinical follow-up was to describe the course and outcome
of the disorders [19, 20]. By nature, it later developed into
a study on mortality. When the final clinical diagnosis was
made in 1985, all 406 subjects met DSM-IV criteria of
major depressive or manic episodes and ICD-10 diagnoses
for major mood disorders, and comprised 186 patients with
UP and 220 patients with BP disorders. The latter group is
subdivided into patients with BP-I (N = 130), patients with
BP-II (N = 60) and patients with mania with or without
minor depressive disorders (N = 30). Three (0.7 %) of the
originally 406 patients could not be followed up because
they had moved abroad. They all belonged to the subgroup
of patients with UP, reduced thereby to 183 cases. All
analyses were restricted to the remaining 403 subjects.
Further methodological details were provided in earlier
papers [19, 21].
Semi-quantitative measures
The degree of remission during intervals was estimated by
the Global Assessment Schedule (GAS) of Endicott et al.
[23]. Information on personality was classified by Klesse
and Zuberbu¨hler on the basis of extensive psychiatric
records and without knowledge of the final diagnosis made
in 1985 [24, 25]. This assessment method was developed
by Po¨ssl and von Zerssen and by von Zerssen [26–28]. The
personality variables were processed at the Max Planck
Institute of Psychiatry in Munich by von Zerssen. They
provide scores for six personality types: ‘melancholic’
according to Tellenbach [29, 30], ‘relaxed, easy-going’,
‘manic’, ‘nervous, tense’, ‘unrealistic, dreamy’ and ‘anx-
ious, insecure’.
Data on mortality
After approval of the application by an ethical committee,
the data on causes of death were provided by the Federal
Office of Statistics of Switzerland.
Statistical analysis
Expected deaths in the entire Swiss population were spe-
cifically determined for each of the following strata: gender
(m/f), 5-year age intervals, each observation year
(1959–2009), and each cause of death (grouped according
to diagnostic entities). The standardised mortality ratio
(SMR) was then determined by the sum of observed deaths
in the patient sample divided by the sum of expected deaths
in the Swiss population, each across all strata [31].
A SMR [1.0 reflects a higher risk of dying for the patients
when compared to that risk in the Swiss population.
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Chi-squared tests were used on frequency data and
Kruskal–Wallis tests for continuous variables. SMRs were
compared to population values and among patient groups
by t tests because SMRs are Poisson-distributed, and
therefore, if N is large, normally distributed.
To examine risk factors of all-cause mortality, we con-
ducted a series of Cox proportional hazard models and
extended Cox regression models with time-dependent
covariates when necessary. The number of remaining years
from admission until death was entered as the time-to-event
variable. For time-dependent covariates, we estimated
constant hazard ratios (HR) for different time intervals
using Heaviside step functions [32]. Time-dependent haz-
ard ratios were estimated separately for the intervals
1–9 years, 10–19 years, 20–29 years, 30–39 years, and
40 years and more (years refer to time after admission).
Initial predictors were sex, long-term medication, number
of medications, family history of suicide, psychotic symp-
toms, alcohol abuse, any substance abuse, presence of a
broken home, social class, social deviation in personality,
intelligence, percentage of time spent in illness, GAS score
during interval, and the above-mentioned six personality
types. Initial predictors were first all tested separately
against mortality rates. Variables that yielded a significant
model fit according to the likelihood-ratio v2 test were
included in a final multiple regression analysis. Variable
exclusion relied on a backward stepwise method.
Analyses were carried out in SPSS 20 for Macintosh and
Stata 11.2 for Windows.
Results
The diagnostic spectrum
The sample is ordered according to the diagnostic spectrum
proposed by Angst [33] into four groups: depression,
bipolar-II, bipolar-I and mania. By nature, pure mania
(M) (N = 14) and mania with mild depression (Md)
(N = 16) were rare, and patients with these conditions had
to be merged into one group comprising 30 subjects only.
Results are reported in Table 1.
There was a clear difference in the sex ratio across the
four groups: women were more common among patients
with BP-II (86.7 %) and with major depression (77.6 %),
whereas they represented 61.5 % of the group with BP-I
and only 50.0 % of the group with mania. Overall, 23.3 %
of the patients with mania were still living; they were
significantly younger than the other patients, of whom only
10.5 % were alive. The patients with mania and BP-I had
an earlier onset of illness than those with MDD and BP-II:
in about one quarter before the age of 20. First admissions
were lowest in the BP-I group (19.2 %) and highest in the
MDD group (56.8 %).
A positive family history of death by suicide was less
common among the patients with mania (3.3 %), whereas
the other three groups (MDD 19.1 %, BP-II 30.0 % and
BP-I 23.1 %) did not differ significantly in this respect. As
expected, the patients with mania had by far the lowest
suicide rate (3.3 %), whereas 15.05 % of the patients with
major depression had died by suicide. It is remarkable that
only one further suicide had occurred (n.s.) since the pre-
vious follow-up 6 years earlier. Over their lifetimes,
41.0 % of patients with depression, 45.0 % of patients with
BP-II, 37.7 % of patients with BP-I but only 10.9 % of
manic patients had attempted suicide.
The opposite is true with regard to psychotic symptoms,
which were observed in 66.7 % of patients with mania and
in 61.5 % of patients with BP-I as compared to 23.3 % of
patients with BP-II and 26.3 % of depressed patients.
There were no great overall differences regarding
comorbid substance use disorders, but alcohol use disorders
were clearly more frequent among the patients with mania
and with BP-I, while abuse of sedatives and analgesics was
more common in the patients with depression and those
with BP-II. With respect to socio-demographic data, there
were only minor differences between the four groups.
For descriptive purposes, we also listed the frequency of
treatment and duration of long-term medication given to
the four groups. The two bipolar patient groups were
clearly more often treated for longer periods (BP-I 66.9 %
and BP-II 53.3 %) than the patients with unipolar depres-
sion (37.2 %) and with mania (33.3 %).
The six personality types showed interesting distribu-
tions across the mood spectrum. As expected, the melan-
cholic, the anxious, insecure and the unrealistic, dreamy
types were most frequent among patients with MDD,
whereas the three other types (relaxed, easy-going; manic;
nervous, tense) were most pronounced among patients with
mania.
Unipolar and bipolar patients: living versus deceased
A comparison of the 46 patients still living with the 357
who had died revealed no significant differences with
regard to school education, broken home, psychotic fea-
tures or substance use disorders (Table 2). However, there
were significant differences in their personality types:
fewer anxious, insecure patients with unipolar depression
had died, and, among patients with BP, those still living
were more frequently of the manic and the relaxed, easy-
going personality types. Generally, among the patients still
living, whether unipolar or bipolar, the unrealistic, dreamy
personality type was more common.
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Table 1 Characteristics of diagnostic subgroups in 2009
D (MDD) Dm (BP-II) MD (BP-I) M(d) (Maniaa) p (1–4)
(1) (2) (3) (4)
Subjects (N) 183 60 130 30
N (%) N (%) N (%) N (%)
Males 41 8 50 15 .0001
Female 142 (77.6) 52 (86.7) 80 (61.5) 15 (50.0)
Family history of suicides 35 (19.1) 18 (30.0) 30 (23.1) 1 (3.3) .03
Education
Special schooling 14 (7.6) 9 (15.0) 25 (19.4) 1 (3.3) .002
Primary/secondary school 161 (88.9) 48 (80.0) 89 (69.0) 27 (90.0)
Higher education 8 (4.4) 3 (5.0) 15 (11.6) 2 (6.7)
Median (Q1–Q3) Median (Q1–Q3) Median (Q1–Q3) Median (Q1–Q3)
Age at onset 46 (31–57) 37 (26–47) 26 (21–39) 28 (20–37) .0000
Age at follow-up/death 77 (67–83) 79 (72.5–86) 74.5 (65–80) 74.5 (65–77) .001
Personality type
Melancholic type 56 (44–64) 50 (33–60) 28 (17–50) 20 (17–35) .0000
Relaxed, easy-going type 36 (35–50) 38 (28–44) 30 (26–50) 42.5 (21–52) .09
Manic type 19 (14–25) 21 (13–31) 19 (13–36) 32 (17–48) .02
Nervous, tense type 16 (12–20) 17(13–25) 17(12–28) 23.5(13–41) .12
Unrealistic, dreamy type 30 (21–39) 27 (19–37) 20 (13–32) 17 (10–24) .0000
Anxious, insecure type 33 (25–39) 27 (20–35) 22 (15–31) 18 (12–22) .0000
N (%) N (%) N (%) N (%)
First admissions 104 (56.8) 22 (36.7) 25 (19.2) 12(40.0) .0001
Psychotic features 26.3 23.3 61.5 66.7 .0001
Suicide attempts 41.0 45.0 37.7 10.0 .008
Substance use disorders (SUD) 10.2 11.7 16.9 10.0 .34
Alcohol use disorders 5.5 3.3 14.6 10.0 .02
Sedatives, analgesics 4.9 11.7 3.1 0 .04
Long-term medication (C6 months)
Lithium 6.3 23.3 42.3 23.3 .0001
Neuroleptics 29.5 36.4 63.9 33.3 .0001
Antidepressants 33.9 50.0 50.6 9.1 .0005
No long-term medication 62.8 46.7 33.1 66.7 .0001
Any long-term medication 37.2 53.3 66.9 33.3
Mean (s) Mean (s) Mean (s) Mean (s)
Long-term medication (years)
Lithium 7.5 (2.4) 4.7 (4.4) 8.2 (6.4) 6.5 (3.8) .23
Neuroleptics 4.8 (5.0) 7.6 (7.3) 7.3 (5.4) 3.2 (3.9) .004
Antidepressants 5.1 (4.8) 7.0 (4.6) 3.3 (3.0) 0.0 .001
N (%) N (%) N (%) N (%)
Mortality (2009)
Deceased (N = 352) 165 (90.2) 53 (88.3) 116 (89.2) 23 (76.7) .20
Living (N = 46) 18 (9.8) 7 (11.7) 14 (10.8) 7 (23.3)
Deaths by suicide (N = 46) 28 (15.3) 4 (6.7) 13 (10.0) 1 (3.33) .10
a Including mania with mild depression
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Causes of death
A total of 357 (88.6 %) of the 403 patients had died. With
the exception of the BP-II group (with the highest pro-
portion of women), the other three groups of patients with
mood disorders had a significant elevation in overall
mortality (SMRs): MDD (1.57), BP-I (1.86), M(d) 1.93 as
shown in Table 3 on causes of death. Two findings are of
particular interest: first, the systematic increase in cardio-
vascular mortality from MDD via the bipolar subgroups to
mania. The risk of cardiovascular death among patients
with MDD was only slightly higher (SMR = 1.32, n.s.),
twofold higher among patients with BP-I disorder (SMR
1.99), but threefold higher among patients with mania
(SMR 3.17). Second, deaths by suicide were most elevated
among patients with MDD (SMR 23.6) and with BP-I
(SMR 12.0); in the other two patient groups, the SMRs
were less elevated and not significant probably owing to
the smaller number of cases. The survival curves demon-
strate the early occurrence of suicides in the course of the
illness. Only among patients with MDD did suicide persist
as a cause of death into old age: in the previous 12 years,
two depressed patients but not a single patient with bipolar
disorder or mania had died by suicide (Fig. 1).
Survival analysis
Simple regression of patients with MDD and BP
In simple analyses, the statistically significant predictors of
increased all-cause mortality varied to a certain extent
between unipolar depressed and bipolar patients.
In patients with UP predictors were higher age at first
episode, higher proportion of total observation time spent
in illness, lower GAS score during the interval between
episodes, personality type (low anxious, insecure; low
unrealistic, dreamy; high nervous, tense), repeated as
opposed to first hospitalisation, lack of long-term medica-
tion and low psychotic symptoms. In patients with BP the
predictors were higher age at first episode, higher
Table 2 Characteristics of unipolar and bipolar patients, living versus deceased
Unipolar Bipolar
Alive Dead p Alive Dead p
N* 18 165 28 192
N (%) N (%) N (%) N (%)
School education
Special schooling 0 8 (4.8) .26 4 (14.3) 16 (8.4) .12
Primary/secondary school 18 (100) 143 (86.7) 23 (82.1) 141 (73.8)
Higher education 0 14 (8.5) 1 (3.6) 34 (17.8)
Broken home
Yes 6 (33.3) 58 (35.2) .88 4 (14–3) 34 (17.7) .66
No 12 107 24 158
Psychotic
Yes 14 (77.8) 121 (73.3) .69 12 (42.9) 94 (49.0) .55
No 4 (19.0) 44 (26.7) 16 (57.1) 98 (51.0)
Substance use disorders
Yes 0 19 (11.5) .13 3 (10.7) 29 (15.1) .54
No 18 (100) 146 (88.5) 25 (8.3) 163 (84.9)
Median (Q1–Q3) Median (Q1–Q3) Median (Q1–Q3) Median (Q1–Q3)
Personality type
Melancholic type 57.5 (56–64) 55 (43.64) .12 46 (19–57) 33 (19–52) .30
Relaxed, easy-going type 34.5 (28–41) 36 (28–45) .72 46 (33–53) 32 (18–47) .006
Manic type 18 (15–19) 19 (14–25) .42 27 (18–48) 20 (12–35) .02
Nervous, tense type 16.5 (12–20) 16 (12–20) .81 20 (15–43) 17 (12–28) .08
Unrealistic, dreamy type 41 (76–48) 28 (21–36) .0000 31 (18–38) 21 (13–32) .05
Anxious, insecure type 43.5 (38–42) 29 (20–37) .0000 26 (18–34) 23 (15–32) .17
* See Table 3 for SMR
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proportion of total observation time spent in illness, lower
GAS score during the interval, personality type (low
unrealistic, dreamy; low relaxed, easy-going), male sex,
repeated as opposed to first hospitalisations, lack of long-
term medication, low psychotic symptoms, low level of
education and positive family history of suicide.
Substantial covariance was found between the unreal-
istic, dreamy and the anxious, insecure personality types,
and between the GAS score during the interval and the
proportion of total observation time spent in illness. To
avoid multi-collinearity in the multiple analysis, we
retained only the stronger bivariate predictor of the inter-
related pairs, that is, anxious, insecure personality type and
the proportion of total observation time spent in illness in
patients with UP, and the GAS interval score in patients
with BP. The assumption of proportional hazards was not
violated for the anxious, insecure, the unrealistic, dreamy,
and the relaxed, easy-going personality types, for educa-
tional level and for the GAS score during interval. All other
predictors were time-dependent.
Multiple regression of patients with MDD
Risk factors of mortality in patients with UP are shown in
Table 4. The anxious, insecure personality type yielded a
weak effect, a standard deviation increase reduced the
mortality risk by 20.6 % (HR = 0.829). The nervous, tense
type markedly increased the hazard ratio (HR = 4.134;
313.4 %), but the effect was observed only during years
40–52 after entry into the study. The hazard ratio repre-
sented by the proportion of time ill was slightly increased
Table 3 Mood disorder subtypes and causes of death
Cause of death D (MDD) Dm (BP-
II)
MD
(BP-I)
M(d)
(mania)
Deaths (N) 161 53 116 23
%
Neoplasm 15.8 7.6 17.2 8.7
Cardiovascular
disease
27.9 50.9 33.6 47.8
Cerebrovascular
disease
9.7 7.6 5.2 8.7
Accident 4.2 1.9 5.2 4.4
Suicide 17.0 7.6 11.2 4.4
Other 23.0 17.0 24.1 13.0
SMR
Neoplasm 1.08 0.40(*) 1.20 0.61
Cardiovascular
disease
1.32 1.60(*) 1.99** 3.17*
Cerebrovascular
disease
0.95 0.52 0.73 1.37
Accident 1.74 0.54 2.36 1.99
Suicide 23.57*** 9.88 12.02** 4.32
Other 1.50* 0.74 1.89* 0.97
Total 1.57*** 1.10 1.86*** 1.93*
* p \ .05, ** p \ .01, *** p \ .001, (*) p \ .1, compared to Swiss
population
Fig. 1 Survivorship of suicide by diagnosis in 403 patients with
mood disorder. DD major depressive disorder, Dm bipolar-II disorder,
MD bipolar-I disorder, M(d) mania or mania with minor depressive
syndromes
Table 4 Final model for multiple risk factors of mortality in patients
with unipolar depression
Predictors Hazard ratio (HR) 95 % CI Sig.
Anxious, insecure typea 0.829 0.690–0.997 0.047
Nervous, tense typea
40–52 years 4.134 1.046–16.340 0.043
Proportion of time illa
1–9 years 1.512 1.248–1.832 0.000
Long-term medication
1–9 years 0.296 0.128–0.682 0.004
Age at first episodea
1–9 years 1.406 1.017–1.943 0.039
10–19 years 2.821 1.935–4.114 0.000
20–29 years 2.117 1.349–3.321 0.001
30–39 years 1.862 1.098–3.159 0.021
40–52 years 3.428 1.449–8.107 0.005
Psychotic symptoms
1–9 years 0.198 0.047–0.826 0.026
Repeated hospitalisations
20–29 years 2.061 0.995–4.270 0.052
30–39 years 3.469 1.540–7.814 0.003
Time-dependent predictors are divided into separate intervals. Time
refers to years after study entry
a Standardised continuous measure: The HR refers to 1 standard
deviation increase in the respective scale
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during the first 9 years (HR = 1.512). Long-term medi-
cation reduced the mortality risk more than threefold dur-
ing the first 9 years (HR = 0.296) but yielded no
significant associations thereafter. A higher age at first
episode significantly increased the mortality risk through-
out the 52 years of the study (HR = 1.406–3.428). As
expected, the hazard ratio was highest during the last
interval from years 40–52 (HR = 3.428). Conversely,
psychotic symptoms during the first 9 years reduced the
hazard ratio (HR = 0.198). If the patient’s admission at
study entry was a readmission, mortality risk was increased
during years 20–29 (HR = 2.061) and 30–39 (HR =
3.469).
Multiple regression of patients with BP
Different predictors were found with respect to patients
with BP (see Table 5). A relaxed, easy-going personality
lowered the mortality risk by 31.6 % (HR = 0.760.). A
standard deviation increase in the GAS interval score
reduced the mortality risk by 64.7 % (HR = 0.607). Long-
term medication considerably reduced the mortality risk
during the first 19 years of the study (HR = 0.072–0.312)
and being female reduced it from years 20–39
(HR = 0.233–0.372). Except during the first 9 years, a
higher age at first episode was again significantly associ-
ated with an increased hazard ratio throughout the obser-
vation period (HR = 1.814–3.369). Having a higher
education reduced the mortality risk over the whole period
of observation by 55.5 % (HR = 0.643). Psychotic symp-
toms reduced the mortality risk from years 10–29
(HR = 0.195–0.511). Finally, we found that, among
patients with BP (unlike those with UP), the mortality risk
increased in association with deaths by suicide in relatives
for the years 30–39 (HR = 3.215) and 40–52 (HR =
4.994).
Discussion
This study on mortality has several strengths: it covers a
broad spectrum of patients with different subgroups of
mood disorders, it is a prospective study conducted over
decades until 90 % of the patients had died, and it includes
a number of personality characteristics.
Unsurprisingly, we found the overall mortality among
patients with severe mood disorders to be elevated, which is
in agreement with most of the literature mentioned in the
introduction. But in addition, our data demonstrate in par-
ticular the practical relevance of distinguishing between
subgroups of mood disorders (MDD, BP-II, BP-I, mania). An
exception to these elevated mortality rates was patients with
BP-II disorders (N = 53) with an overall SMR of 1.10 (n.s.).
This group had the highest rate of women (86.7 %). Only 8
patients were males, which is of course a severe limitation of
the findings. BP-II patients manifested a trend (p \ .10) to
lower mortality by neoplasm (SMR 0.40) and a slightly
elevated risk for cardiovascular disease (SMR 1.60).
Deaths by suicide were systematically associated with
the depressive component of the diagnostic spectrum. They
were 4–23-fold more common than in the normal popula-
tion and about twice as frequent among patients with MDD
(SMR 23.1) than among those with BP-I disorder (SMR
12.0). Suicides among patients with BP-II (SMR 9.9) and
mania (SMR 4.3) were also considerably elevated but the
findings did not reach significance, apparently owing to the
small number of cases.
The reverse was found for cardiovascular deaths, which
increased systematically with the manic component. While
patients with MDD (SMR 1.32) did not differ significantly
from controls and patients with BP-II showed a trend to an
elevation (SMR 1.6, p \ .10), patients with BP-I had
double and patients with mania triple the risk of dying from
a cardiovascular disorder (SMR 3.17) not yet reported in
the literature.
Table 5 Final model for multiple risk factors of mortality in patients
with bipolar disorder
Predictors Hazard ratio
(HR)
95 % CI Sig.
Relaxed, easy-going
typea
0.760 0.625–0.925 0.006
GAS interval scorea 0.607 0.492–0.749 0.000
Long-term medication
1–9 years 0.072 0.009–0.600 0.015
10–19 years 0.312 0.095–1.024 0.055
Female gender
20–29 years 0.233 0.117–0.465 0.000
30–39 years 0.372 0.122–1.134 0.082
Age at first episodea
10–19 years 1.814 1.012–3.252 0.045
20–29 years 2.757 1.783–4.262 0.000
30–39 years 3.197 1.773–5.766 0.000
40–52 years 3.369 1.425–7.965 0.006
Psychotic symptoms
10–19 years 0.195 0.040–0.941 0.042
20–29 years 0.511 0.263–0.993 0.048
Higher education 0.643 0.429–0.963 0.032
Suicide history in relatives
30–39 years 3.215 1.379–7.492 0.007
40–52 years 4.994 1.735–14.372 0.003
Time-dependent predictors are divided into separate intervals. Time
refers to years after study entry
a Standardised continuous measure: The HR refers to 1 standard
deviation increase in the respective scale
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The other findings are in line with recent papers. Fied-
orowicz et al. [34] found patients with BP-I had more than
double the risk of dying from a cardiovascular disorder
than those with BP-II, compatible with the papers of Gar-
cia-Portilla et al. [35], and the reviews of Weiner et al. [18]
and Munk Laursen et al. [16].
On the other hand, there is an ongoing debate about the
elevation and causation of cardiovascular mortality among
depressed patients. Depression following myocardial
infarction was found to be clearly associated with higher
mortality [36]; a bidirectional relationship between car-
diovascular disease and depression was stressed in the
review of Baune et al. [37]; a high level of methodological
heterogeneity was found in the review of van der Kooy
et al. [38] and a meta-analysis of 54 studies found uncer-
tainty as to whether depression is an independent risk
factor for coronary heart disease [39]. Our unclear result
regarding higher mortality among depressed patients is in
accord with this uncertainty.
The increased cardiovascular deaths in patients with
mania may be due to factors of lifestyle (such as nutrition
and alcohol consumption) in contrast to the more cautious
lifestyle of patients with an anxious, insecure personality
type, more prominent in patients with MDD. An associa-
tion between psychological distress and cardiovascular
mortality was recently found in meta-analyses of 10 pro-
spective cohort studies from England [40]. The associa-
tions between mortality and a positive family history of
deaths by suicide and a severe course of the illness
expressed by the percentage of time spent in episodes
during the follow-up period are unsurprising. It is impor-
tant to note that a later age at onset is related to an
increased mortality in both the UP and BP patient groups;
late-onset affective disorder thus requires special attention
and the prescription of long-term medication; the latter was
found to be effective in lowering mortality in this study.
Of special interest are the associations between per-
sonality types and mortality: having a nervous, tense per-
sonality type increased mortality among depressed patients.
A similar relationship with suicide attempts was found
earlier in a large prospective study of young men tested at
age 19 and followed up to the age of 31 [41]. This is
compatible with the literature on aggression or impulsivity
[42, 43] and suicidality [44, 45].
An unexpected finding was the protective effect of being
anxious and insecure in patients with MDD. Intuitively,
this makes sense, but we were unable to associate this
effect with any specific cause of death; for instance, we did
not find that anxious, insecure patients had a lower accident
or suicide rate. So we hypothesise that this personality type
is associated with a more cautious lifestyle in general.
Patients with bipolar disorder had very different
predictors of mortality: mortality was reduced by a higher
education (an effect of lifestyle?) and increased by a family
history of death by suicide (significantly more common
in the BP than in the UP patient group). This finding is
in agreement with recent papers [44, 46, 47]. A better
inter-episode remission lowered the mortality rate, as did
long-term medication. A relaxed, easy-going personality
type was also linked with lower mortality and may be an
indicator of a lower stress sensitivity. The associations of
personality types with subtypes of affective disorders as
indicated in Table 1 are in almost perfect agreement with
von Zerssen’s original concept of such relationships [48].
Of interest are the differences between patients with
mania and those with BP-I disorders. Overall, the mortality
was very high in both groups (SMR 1.93 vs. 1.86),
although there were marked differences in their respective
rates of suicide attempts (10 vs. 37.7 %) and suicides (4.4
vs. 11.2 %), the latter illustrated also by the SMRs (4.32 vs.
12.02). Compatible with these findings is the much lower
family history for suicides among patients with mania
(3.3 %) than patients with BP-I disorders (23.1 %). Finally,
manic patients tended to score higher on the manic type
and relaxed, easy-going type of personality than did
patients with BP-I disorder. In this context, the results of
the NCS-A study of 10,123 adolescents, which point to a
considerable lifetime prevalence of mania alone (1.7 %)
are relevant [49]. These findings cannot prove mania to be
an independent disorder but they do suggest that it should
be distinguished from BP-I disorder for the purpose of
further research.
This study has the following limitations: all patients had
been admitted to a psychiatric hospital and represent only
the most severe subgroup of persons suffering from mood
disorders in the general population. The clinical follow-up
lasted 25 years and ended in 1985; after that, only mor-
tality data were available. The treatment received after
1985 is unknown. The number of patients with mania
(N = 30) or BP-II (N = 60) was comparatively small,
which may have led to type II errors in the comparison of
SMRs. We did not correct the a level in multiple survival
analyses because the effect sizes achieved were high and
the probability of type I errors thus low. However, because
of the small N in some analyses, a correction of the a level
would have increased the type II error markedly. Post hoc
power analyses revealed that an a correction would have
reduced our statistical power (1 - b) to an non-acceptable
degree of 0.5 or lower, whereas without correction, it was
0.8 or higher.
Conclusions
There is a need for prospective studies of mood disorder
patients which follow them to the end of their lives. The
432 Eur Arch Psychiatry Clin Neurosci (2013) 263:425–434
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differences in the causes of death across the mood spec-
trum from depression via bipolar subgroups to mania
confirm the validity of the distinction between the diag-
nostic groups.
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